Predict your next investment

Venture Capital
cdibbiosciencevc.com

See what CB Insights has to offer

Investments

74

Portfolio Exits

34

Funds

1

About CDIB BioScience Venture Management

CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US and Taiwan. The majority of management team was spun-off from CDIB (China Development Industrial Bank) in 2001, one of the largest investment banks in Asia. CDIB remains to be a minor investor to the fund. The team has invested over 50 biotech companies globally in the past 10 years and majority of them successfully listed in global stock market exchanges or acquired.

CDIB BioScience Venture Management Headquarter Location

9191 Towne Centre Drive Suite 575

San Diego, California, 92122,

United States

858-552-6808

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CDIB BioScience Venture Management

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find CDIB BioScience Venture Management in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

CDIB BioScience Venture Management Investments

74 Investments

CDIB BioScience Venture Management has made 74 investments. Their latest investment was in OptiMedica as part of their Series D - II on October 10, 2009.

CBI Logo

CDIB BioScience Venture Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/20/2009

Series D - II

OptiMedica

$5M

No

Alloy Ventures, Biotechnology Development Fund, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital

1

8/13/2009

Series D

OptiMedica

$25.04M

No

Alloy Ventures, Biotechnology Development Fund, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital

1

7/17/2008

Series C

Light Sciences Oncology

$40.1M

Yes

Adams Street Partners, Burrill & Company, CDIB Capital Group, Deephaven Capital Management, EW Healthcare Partners, Johnson & Johnson Innovation, Larkspur Capital, Malaysian Life Sciences Capital Fund, New Science Ventures, Novo Holdings, and Scandinavian Life Science Venture

2/18/2008

Series C

Subscribe to see more

$99M

Subscribe to see more

10

10/11/2007

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/20/2009

8/13/2009

7/17/2008

2/18/2008

10/11/2007

Round

Series D - II

Series D

Series C

Series C

Series D

Company

OptiMedica

OptiMedica

Light Sciences Oncology

Subscribe to see more

Subscribe to see more

Amount

$5M

$25.04M

$40.1M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Alloy Ventures, Biotechnology Development Fund, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital

Alloy Ventures, Biotechnology Development Fund, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital

Adams Street Partners, Burrill & Company, CDIB Capital Group, Deephaven Capital Management, EW Healthcare Partners, Johnson & Johnson Innovation, Larkspur Capital, Malaysian Life Sciences Capital Fund, New Science Ventures, Novo Holdings, and Scandinavian Life Science Venture

Sources

1

1

10

10

CDIB BioScience Venture Management Portfolio Exits

34 Portfolio Exits

CDIB BioScience Venture Management has 34 portfolio exits. Their latest portfolio exit was Sonics on March 13, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/13/2019

Acquired

1

1/30/2019

Acquired

2

8/19/2013

Acquired

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

3/13/2019

1/30/2019

8/19/2013

00/00/0000

00/00/0000

Exit

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

2

2

10

10

CDIB BioScience Venture Management Fund History

1 Fund History

CDIB BioScience Venture Management has 1 fund, including CDIB BioScience Ventures I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/7/2003

CDIB BioScience Ventures I

Multi-Stage Venture Capital

$80M

1

Closing Date

1/7/2003

Fund

CDIB BioScience Ventures I

Fund Type

Multi-Stage Venture Capital

Status

Amount

$80M

Sources

1

CDIB BioScience Venture Management Team

4 Team Members

CDIB BioScience Venture Management has 4 team members, including current President, Tai-Sen Soong.

Name

Work History

Title

Status

Tai-Sen Soong

President

Current

Meihui Kuo

Senior Vice President

Former

Chin Tuck Lee

Senior Director

Former

Grace I Yu

Senior Director

Former

Name

Tai-Sen Soong

Meihui Kuo

Chin Tuck Lee

Grace I Yu

Work History

Title

President

Senior Vice President

Senior Director

Senior Director

Status

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.